FDA Form FDA 3741 Update 2026: Tobacco Product Registration & Listing Compliance Guide

The U.S. Food and Drug Administration (FDA) has launched a redesigned Form FDA 3741 to streamline tobacco product establishment registration and product listing submissions.

Announced on September 29, 2026, the update consolidates two previously separate forms into a single Form FDA 3741 covering regulated tobacco product categories. The redesigned form is intended to simplify submissions, reduce unnecessary data entry, and help manufacturers identify only the sections relevant to their specific submission.

The updated process is particularly important for domestic tobacco product manufacturers preparing for the December 31, 2026, annual establishment registration deadline.

FDA strongly encourages electronic submission through the Tobacco Registration and Listing Module – Next Generation (TRLM NG), which supports electronic registration, product listing updates, document submission and FDA receipt acknowledgements.

What Has Changed with Form FDA 3741?

Previously, manufacturers used different forms depending on the tobacco product category.

The redesigned Form FDA 3741 now provides a unified approach covering regulated tobacco products, including:

• Cigarettes
• E-cigarettes
• Electronic nicotine delivery systems
• Smokeless tobacco
• Heated Tobacco Products
• Oral nicotine products, including nicotine pouches
• Other regulated tobacco product categories

FDA has retired the previous versions of Forms FDA 3741 and 3741a as of September 28, 2026. The redesigned Form FDA 3741 replaces those forms for establishment registration and product listing submissions.

The update is designed to eliminate the need for manufacturers to determine which legacy form applies to their product category.

Why Did FDA Redesign Form FDA 3741?

The redesigned form is part of FDA's effort to make tobacco regulatory submissions more efficient.

The updated form includes a submission checklist that directs users toward the portions relevant to their submission.

This means manufacturers can focus on applicable information rather than completing unnecessary sections.

FDA also stated that manufacturers updating existing registrations can update specific information without resubmitting unchanged portions of their registration. Existing registrations and product listings remain available in TRLM NG. Manufacturers therefore do not need to completely resubmit their existing registration merely because FDA changed the form.

December 31, 2026: Key Tobacco Compliance Deadline

Domestic tobacco product establishments must complete their annual establishment registration by December 31 each year.

In addition, product listing is a biannual requirement, with submission deadlines on:

• June 30
• December 31

The biannual requirement applies when qualifying changes have occurred to products or previously submitted listing information.

Manufacturers should therefore assess both their establishment registration and product listing data before December 31, 2026, deadline.

Who Must Register With FDA?

Under Section 905 of the FD&C Act, domestic establishments engaged in manufacturing tobacco products are subject to FDA establishment registration and product listing requirements.

FDA describes covered activities including establishments that manufacture, prepare, compound, process, repackage or relabel tobacco products.

The requirements apply across a broad range of tobacco products, including cigarettes, cigars, smokeless tobacco, e-liquids, electronic nicotine delivery systems, nicotine pouches and other regulated tobacco products.

New establishments must register and list applicable tobacco products when they begin manufacturing regulated tobacco products.

Existing establishments must renew their registration annually.

What Is Product Listing?

Tobacco product listing allows FDA to receive information about the products manufactured by a domestic tobacco establishment for commercial distribution.

Product listing information can include product identification information and relevant labeling, advertising and consumer information.

Manufacturers may need to update their listings when certain material changes occur.

Examples include:

1. New Product Introduced

A tobacco product not previously included in the manufacturer's product list is introduced into commercial distribution.

2. Product Discontinued

Manufacturing of a previously listed product has ceased.

3. Product Resumed

Manufacturing of a product previously reported as discontinued has resumed.

4. Product Name Change

The name of an existing listed product change.

5. Labeling Change

The labeling is associated with a listed product change.

6. Advertising Change

A material change is made to advertising associated with a listed product.

7. Consumer Information Change

Relevant consumer information associated with the product is updated.

8. Other Material Changes

Other changes requiring an update under the applicable FDA requirements should also be evaluated.

FDA states that qualifying product-listing changes are reported during the June and December submission periods.

TRLM NG: FDA's Recommended Electronic Submission Route

FDA strongly recommends electronic submission through the Tobacco Registration and Listing Module – Next Generation (TRLM NG).

TRLM NG is designed to streamline tobacco establishment registration and product listing submissions.

The system can provide:

• Interactive submission functionality
• Electronic registration and listing
• FDA receipt acknowledgement
• Management of existing registration information
• Product listing updates
• Attachment of labeling and advertising materials
• Tracking of submitted materials

FDA also encourages manufacturers to use the new Form FDA 3741b spreadsheet for initial product list submissions or for adding new products to existing product lists.

For companies unable to submit electronically, FDA provides paper submission options.

Form FDA 3741 vs. Form FDA 3741b

The redesigned process introduces an important distinction between the unified registration/listing form and the spreadsheet option for product-list submissions.

FDA states that FDA 3741b can be used for initial product-list submissions or adding new products to an existing product list.

What Does the 2026 Update Mean for Manufacturers?

The redesigned form does not eliminate the underlying regulatory obligations.

Instead, it changes how manufacturers organize and submit required information.

Companies should therefore avoid treating the new form as simply an administrative change.

The transition creates an opportunity to review:

Establishment registration → Product inventory → Product listing → Labeling → Advertising → Consumer information → Submission records

A mismatch between a company's internal product portfolio and its FDA product listing can create compliance challenges.

Key Tobacco Product Registration Compliance Areas

Manufacturers should review the following areas before submitting their 2026 registration.

1. Establishment of Information

Confirm that the establishment's legal name, address, operations and contact information are current.

2. Manufacturing Activities

Review the activities performed at each domestic establishment and ensure the information accurately reflects current operations.

3. Product Portfolio

Reconcile all products currently manufactured for commercial distribution against the FDA product listing.

4. Product Status

Identify products that have been introduced, discontinued or resumed since the previous submission.

5. Product Names

Verify that product names and commercial identifiers match current manufacturing and marketing records.

6. Labeling

Review current labeling and identify changes that may require product-listing updates.

7. Advertising

Assess whether material advertising changes require an update to previously submitted information.

8. Consumer Information

Review consumer-facing information associated with listed products.

9. Supporting Documentation

Maintain appropriate records supporting the information submitted to FDA.

10. Submission Evidence

Retain copies of submissions, acknowledgements and supporting documentation for internal compliance records.

What Happens If Information Is Not Updated?

FDA's registration and listing requirements are statutory requirements under Section 905 of the FD&C Act.

Failure to maintain accurate registration and product-listing information can create regulatory compliance concerns.

Companies should therefore treat annual registration as more than a simple administrative renewal.

The process should include a documented review of the establishment, manufacturing activities and current product portfolio.

This is particularly important for manufacturers managing large numbers of SKUs, multiple facilities, frequent labeling changes or rapidly evolving nicotine-product portfolios.

FAQs

1. What is Form FDA 3741?

FDA 3741 is used for tobacco product establishment registration and product listing submissions. FDA redesigned the form in September 2026 to consolidate previously separate forms covering different tobacco product categories.

2. When is the 2026 annual registration deadline?

Domestic tobacco product establishments must complete their annual establishment registration by December 31, 2026.

3. Are Forms FDA 3741 and 3741a still separate?

No. FDA retired the previous versions of Forms FDA 3741 and 3741a on September 28, 2026. The redesigned Form FDA 3741 provides a unified form covering regulated tobacco product categories.

4. What is TRLM NG?

The Tobacco Registration and Listing Module – Next Generation is FDA's electronic system for tobacco product establishment registration and product listing submissions. FDA strongly recommends electronic submission through TRLM NG.

5. Do existing manufacturers need to completely resubmit their registration because of the new form?

No. FDA states that previously submitted registrations and product listings remain in TRLM NG. Existing manufacturers are not required to resubmit their entire registration solely because of the form redesign.

6. When are tobacco product listings updated?

Certain product-listing updates are submitted twice each year, by June 30 and December 31, when qualifying changes have occurred.

7. Can manufacturers submit it on paper?

Yes. Manufacturers unable to submit electronically through TRLM NG may use the applicable paper submission process. FDA nevertheless strongly recommends electronic submission.

Conclusion

The FDA's September 2026 redesign of Form FDA 3741 represents an important procedural change for tobacco product manufacturers preparing establishment registration and product-listing submissions.

The consolidation of previously separate forms into one unified form is intended to simplify submissions and make the registration process more efficient.

However, the underlying compliance responsibilities remain.

For tobacco product manufacturers, accurate establishment information + complete product listings + current labeling information + appropriate change assessment + timely submission remain essential components of regulatory compliance.

With the December 31, 2026, deadline approaching, manufacturers should reconcile their establishment and product information early, identify qualifying changes and ensure their TRLM NG submissions are complete and internally supported.

A structured regulatory review can help companies identify discrepancies before submission and maintain better control over their tobacco product regulatory records.

How Maven Regulatory Solutions Can Help

Maven Regulatory Solutions supports tobacco and regulated-product companies with regulatory strategy, submission readiness and compliance support.

Our support can include:

• FDA Tobacco Regulatory Compliance
• Form FDA 3741 Submission Support
• Establishment Registration Assessment
• Tobacco Product Listing Review
• TRLM NG Submission Readiness
• Product Portfolio Reconciliation
• Labeling & Advertising Compliance Review
• Regulatory Documentation Review
• Change Assessment & Lifecycle Support
• FDA Submission Strategy
• Compliance Gap Assessment
• Regulatory Intelligence & Monitoring

Maven Regulatory Solutions — Science. Compliance. Impact.